Breaking News

You are here » Indian-Commodity  :  Investment  :  Vanguard Group acquires 1.36 million shares of Graphite India

19-Mar2018

Vanguard Group acquires 1.36 million shares of Graphite India

Vanguard Group has acquired 1.36 million equity shares of Graphite India for around Rs 105.50 crore. The investment management company has bought these shares for an average price of Rs 776.06 per share on the NSE on March 16, 2018.

Graphite India is the pioneer in India for manufacture of Graphite Electrodes as well as Carbon and Graphite Speciality products.


Related News

View all news

SpiceJet to start 12 new domestic flights from March 31

SpiceJet will start 12 new direct flights on its domestic network from March 31, 2019. The airline is the first Indian carrier to introduce daily direct flights on the Bhopal-Surat-Bhopal, Gorakhpur-Mumbai-Gorakhpur......

Aditya Birla Fashion to start apparel manufacturing plant in Odisha: Report

Aditya Birla Fashion and Retail is reportedly to start a new apparel manufacturing plant in Rayagda district of Odisha with an investment of Rs 114 crore. This unit will have a capacity to produce 3.6......

Power Grid gets investment approval for 'Northern Region System Strengthening - XL'

Power Grid Corporation of India has received an investment approval for 'Northern Region System Strengthening - XL' at an estimated cost of Rs 572.98 crore with commissioning schedule of 22 months from......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......